Skip to main content
. 2023 Sep 18;15(9):e45454. doi: 10.7759/cureus.45454

Table 2. List of first-, second-, and third-line approved therapies for RRMS.

RRMS: relapsing-remitting multiple sclerosis

Source: [7]

First line Second line Third line
Interferon beta Natalizumab Mitoxantrone
Glatiramer Fingolimod Alemtuzumab
Teriflunomide Azathioprine Ocrelizumab 
Dimethyl fumarate Cladribine